Prot #MRG201-30-201: A Phase 2, Double-blind, Placebo-Controlled Study to Investigate the Efficacy, Safety and Tolerability of MRG-201 Following Intradermal Injection in Subjects with a History of Keloids

Project: Research project

Project Details

StatusFinished
Effective start/end date6/26/18 → 6/26/21

Funding

  • Novella Clinical, LLC (Prot #MRG201-30-201 // Prot #MRG201-30-201)
  • miRagen Therapeutics, Inc. (Prot #MRG201-30-201 // Prot #MRG201-30-201)